Eli Lilly Files 8-K Reporting Results; Press Release Aug 5, 2026

What Happened
Eli Lilly & Company (LLY) filed a Form 8-K on August 5, 2026 under Item 2.02 (Results of Operations and Financial Condition) and furnished a press release dated August 5, 2026 as Exhibit 99.1 that communicates the company’s financial results. The report was signed by Donald A. Zakrowski, Senior Vice President, Finance and Chief Accounting Officer, on August 5, 2026.

Key Details

• Filing date: August 5, 2026 (Form 8-K).
• Item reported: 2.02 — Results of Operations and Financial Condition.
• Exhibit 99.1: Press release of Eli Lilly and Company dated August 5, 2026 (contains the detailed results).
• Exhibit 104: Interactive XBRL cover page included in the filing.

Why It Matters
This 8-K notifies investors that Eli Lilly has publicly released updated earnings/financial results; investors should review the attached press release (Exhibit 99.1) for specific figures on revenue, earnings, and any forward-looking statements. The filing does not report executive changes, mergers, or other corporate actions—its primary purpose is to make the company’s recent financial results available to the market.